Cargando…

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response

OBJECTIVES: To determine the prognostic value of patterns of right ventricular adaptation in patients with pulmonary arterial hypertension (PAH), assessed using cardiac magnetic resonance (CMR) imaging at baseline and follow-up. METHODS: Patients attending the Sheffield Pulmonary Vascular Disease Un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goh, Ze Ming, Balasubramanian, Nithin, Alabed, Samer, Dwivedi, Krit, Shahin, Yousef, Rothman, Alexander M K, Garg, Pankaj, Lawrie, Allan, Capener, David, Thompson, A A Roger, Alandejani, Faisal, Wild, Jim M, Johns, Christopher S, Lewis, Robert A, Gosling, Rebecca, Sharkey, Michael, Condliffe, Robin, Kiely, David G, Swift, Andrew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Pulmonary Vascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380507/ https://www.ncbi.nlm.nih.gov/pubmed/35512982 http://dx.doi.org/10.1136/heartjnl-2021-320733

Ejemplares similares

Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension
por: Goh, Ze Ming, et al.
Publicado: (2021)

Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update
por: Alabed, Samer, et al.
Publicado: (2020)

Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
por: Alabed, Samer, et al.
Publicado: (2022)

Non-invasive detection of severe PH in lung disease using magnetic resonance imaging
por: Alkhanfar, Dheyaa, et al.
Publicado: (2023)

Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Alabed, Samer, et al.
Publicado: (2021)

Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography
por: Alkhanfar, Dheyaa, et al.
Publicado: (2022)

Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension
por: Macdonald, Alistair, et al.
Publicado: (2023)

Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study
por: Swift, Andrew J, et al.
Publicado: (2021)

Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction
por: Alabed, Samer, et al.
Publicado: (2022)

A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension
por: Mamalakis, Michail, et al.
Publicado: (2023)

Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
por: Dwivedi, Krit, et al.
Publicado: (2022)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications
por: Garg, Pankaj, et al.
Publicado: (2022)

Pulmonary Hypertension in Association with Lung Disease: Quantitative CT and Artificial Intelligence to the Rescue? State-of-the-Art Review
por: Dwivedi, Krit, et al.
Publicado: (2021)

Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension
por: Shahin, Yousef, et al.
Publicado: (2022)

Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension
por: Swift, Andrew J., et al.
Publicado: (2020)

The Left Atrial Area Derived Cardiovascular Magnetic Resonance Left Ventricular Filling Pressure Equation Shows Superiority over Integrated Echocardiography
por: Grafton-Clarke, Ciaran, et al.
Publicado: (2023)

CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension
por: Shahin, Yousef, et al.
Publicado: (2022)

Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements
por: Alandejani, Faisal, et al.
Publicado: (2022)

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis
por: Swift, Andrew J, et al.
Publicado: (2020)

Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension
por: Alabed, Samer, et al.
Publicado: (2023)

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension
por: Goddard, Julia C, et al.
Publicado: (2017)

Fully automatic cardiac four chamber and great vessel segmentation on CT pulmonary angiography using deep learning
por: Sharkey, Michael J., et al.
Publicado: (2022)

Interventricular septal angle can be used to predict which patients have combined postcapillary or precapillary pulmonary hypertension in left heart disease
por: Hussain, Nehal, et al.
Publicado: (2015)

Evaluating the performance of artificial intelligence software for lung nodule detection on chest radiographs in a retrospective real-world UK population
por: Maiter, Ahmed, et al.
Publicado: (2023)

Assessment of Right Ventricular Function—a State of the Art
por: Hameed, Abdul, et al.
Publicado: (2023)

Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging
por: Johns, C. S., et al.
Publicado: (2017)

Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes
por: Ratwatte, Seshika, et al.
Publicado: (2023)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

THE CLOT THICKENS: DOES THE JOHNSON & JOHNSON COVID-19 VACCINE INCREASE THE RISK OF THROMBUS IN A HYPERCOAGULABLE STATE?
por: RUTENBERG, DAVID, et al.
Publicado: (2021)

Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI
por: Johns, Christopher S., et al.
Publicado: (2018)

Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper
por: Abraham, Paul, et al.
Publicado: (2018)

Prognostic relevance of the right ventricular myo-mechanical index (RV-MMI) in patients with precapillary pulmonary hypertension
por: Greiner, Sebastian, et al.
Publicado: (2018)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry
por: Swift, Andrew J, et al.
Publicado: (2012)

Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension
por: Han, Yuchi, et al.
Publicado: (2018)

Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy
por: Ghio, Stefano, et al.
Publicado: (2016)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hmi5e6gfqhb1nq6c1v1os4d49k